<unk>   sodium is a novel long-acting synthetic indirect inhibitor of coagulation factor Xa. The agent is being developed by Sanofi-Aventis.  It has a similar chemical structure and mechanism of action as fondaparinux, but its elimination half-life of 80 hours is 5 to 6 times longer than that of fondaparix (17 hours). Given its long half life, it can be injected subcutaneously once a week.
Idraparinux
Picloxydine
Casopitant
Asfotase alfa
Crofelemer
Rubitecan
Iofendylate
Sebelipase alfa